OBJECTIVES: To evaluate the efficacy of Oraqix(R) during scaling and root planing (SRP) in comparison with 20% benzocaine and placebo. STUDY DESIGN: 15 patients requiring 4 sessions of SRP were enrolled. For each patient, Oraqix(R), Hurricaine(R), vaseline or no anesthetic product were randomly assigned each to a quadrant. Treatment pain was evaluated on a 100 mm Visual Analog Scale (VAS) and on a Verbal Rating Scale (VRS). The amount of product administered, the need to re-anesthetise, patient and operator satisfaction and the onset of side-effects were also recorded. RESULTS: Oraqix(R) was significantly better than nothing, with a reduction of VAS score to 13.3 units, but without significant differences with Vaseline or Hurricaine(R). Oraqix(R) was better in VRS reduction than not using any anesthetic (p=0.001) or using vaseline (p=0.024), but similar to Hurricaine(R) (p=0.232). CONCLUSIONS: Oraqix(R) effectively controls pain in SRP procedures, with few side-effects and a good acceptance on the part of patients and clinicians.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.